Researchers Submit Patent Application, "Polypeptides And Uses Thereof", for Approval (USPTO 20240067693).
In: Pharma Business Week, 2024-03-18, S. 632-632
serialPeriodical
Zugriff:
This patent application describes a new polypeptide called "Polypeptides And Uses Thereof" that is similar to a synthetic version of human amylin used in diabetes treatments. The new polypeptide aims to improve upon the existing version by addressing its short half-life and tendency to fibrillate. The application provides detailed information about the amino acid sequence and modifications of the polypeptide, including its conjugation to albumin binding moieties and lipidation. It also discusses methods for treating diseases or disorders using the polypeptide and pharmaceutical compositions containing it. This research has potential applications in the development of antidiabetic agents and peptide therapies. [Extracted from the article]
Copyright of Pharma Business Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Researchers Submit Patent Application, "Polypeptides And Uses Thereof", for Approval (USPTO 20240067693).
|
---|---|
Zeitschrift: | Pharma Business Week, 2024-03-18, S. 632-632 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1543-6675 (print) |
Schlagwort: |
|
Sonstiges: |
|